# A Sickle CEll Disease ComplicatioN Trial

> **NCT02604368** · PHASE3 · UNKNOWN · sponsor: **Micelle BioPharma Inc** · enrollment: 210 (estimated)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** SC411
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02604368
- **Lead sponsor:** Micelle BioPharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2019-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02604368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02604368, "A Sickle CEll Disease ComplicatioN Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02604368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*